NO180489B - Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative - Google Patents

Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative Download PDF

Info

Publication number
NO180489B
NO180489B NO923722A NO923722A NO180489B NO 180489 B NO180489 B NO 180489B NO 923722 A NO923722 A NO 923722A NO 923722 A NO923722 A NO 923722A NO 180489 B NO180489 B NO 180489B
Authority
NO
Norway
Prior art keywords
thiolanylthio
oxo
penem
hydroxyethyl
mmol
Prior art date
Application number
NO923722A
Other languages
Norwegian (no)
Other versions
NO923722D0 (en
NO180489C (en
NO923722L (en
Inventor
Robert Alfred Volkmann
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1987/001114 external-priority patent/WO1988008845A1/en
Priority to NO890078A priority Critical patent/NO173654C/en
Publication of NO923722L publication Critical patent/NO923722L/en
Priority claimed from NO890078A external-priority patent/NO173654C/en
Application filed by Pfizer filed Critical Pfizer
Priority to NO923722A priority patent/NO180489C/en
Publication of NO923722D0 publication Critical patent/NO923722D0/en
Publication of NO180489B publication Critical patent/NO180489B/en
Publication of NO180489C publication Critical patent/NO180489C/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Bakgrunn for oppfinnelsen Background for the invention

Foreliggende oppfinnelse angår mellomprodukter for fremstilling av antibakterielle forbindelser som er diastereomere 5R,6S-6-(lR-hydroksyetyl)-2-(cis-l-okso-3-tiolanyltio)-2-penem-3-karboksylsyrer, dvs. 2-(lR-okso-3S-tiolanyltio)-vari-anten av den nedenfor angitte formel (II); de farmasøytisk akseptable salter og in vivo hydrolyserbare estere derav. The present invention relates to intermediates for the production of antibacterial compounds which are diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids, i.e. 2- (1R-oxo-3S-thiolanylthio)-variant of the formula (II) set forth below; the pharmaceutically acceptable salts and in vivo hydrolyzable esters thereof.

Antibakteriell 5R,6S-6-(lR-hydroksyetyl)-2-(cis-l-okso-3-tiolanyltio)-2-penem-3-karboksylsyre som er en diastereomer blanding av to forbindelser, er tidligere omtalt som et verdi-fullt antibakterielt stoff, av Hamanaka, US-patent 4.619.924 og europeisk patentsøknad 130.025. Selv om de har kunnet påvises analytisk, har de rene diastereomere forbindelsene med den gitte struktur hittil ikke vært tilgjengelige. Omtale av en forbedret fremgangsmåte for fremstilling av den diastereomere blandingen fra racemisk cis-3-(acetyltio)tiolan-l-oksyd, som gjør bruk av blandede diastereomere mellomprodukter som ellers er anlaoge med dem som nå benyttes, vil gjenfinnes i en europeisk patentsøknad av Volkmann et al., beregnet offentlig-gjort 27. mai 1987 under nr. 223.397. Antibacterial 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acid, which is a diastereomeric mixture of two compounds, has previously been mentioned as a value- fully antibacterial substance, by Hamanaka, US Patent 4,619,924 and European Patent Application 130,025. Although they have been able to be detected analytically, the pure diastereomeric compounds with the given structure have so far not been available. Mention of an improved process for the preparation of the diastereomeric mixture from racemic cis-3-(acetylthio)thiolane-1-oxide, which makes use of mixed diastereomeric intermediates which are otherwise similar to those now used, will be found in a European patent application by Volkmann et al., published 27 May 1987 under No. 223,397.

Med hensyn til de optisk aktive forløpere, har Brown et al., J. Am. Chem. Soc, vol. 108, s. 2049-2054 (1986) beskre-vet syntesen av (S)-3-hydroksytiolan [ved feiltagelse vist som (R)-isomeren, men i virkeligheten med den omvendte konfigura-sjon av foreliggende (R)-3-hydroksytiolan med formel (XI) nedenfor] ved asymmetrisk hydroborering av 2,3-dihydrotiofen. Partiell enzymatisk oksydasjon av racemisk 3-hydroksytiolan av Jones et al., Can. J. Chem. vol. 59, s. 1574-1579 (1981) gjorde det mulig å gjenvinne 3-hydroksytiolan inneholdende et svakt overskudd av (R)-isomeren. Foreliggende optisk aktive forløper (R)-(2-metansulfonyloksyetyl)oksiran med den nedenfor angitte formel (XIII) hvor R<9> = CH3] og (S)-2-brom-l, 4-di-(metansulfonyloksy)butan [med den nedenfor angitte formel Xa, hvor R<8> = CH3] er kjente forbindelser som begge kan fremstilles i henhold til Shibata et al., Heterocycles, vol. 24, s. 1331-1346 (1986); førstnevnte dessuten også etter Boger et al., J. Org. Chem., vol. 46, s. 1208-1210 (1981). With respect to the optically active precursors, Brown et al., J. Am. Chem. Soc, vol. 108, pp. 2049-2054 (1986) described the synthesis of (S)-3-hydroxythiolane [mistakenly shown as the (R)-isomer, but in reality with the reverse configuration of the present (R)-3- hydroxythiolane of formula (XI) below] by asymmetric hydroboration of 2,3-dihydrothiophene. Partial Enzymatic Oxidation of Racemic 3-Hydroxythiolane by Jones et al., Can. J. Chem. Vol. 59, pp. 1574-1579 (1981) made it possible to recover 3-hydroxythiolane containing a slight excess of the (R)-isomer. Present optically active precursor (R)-(2-methanesulfonyloxyethyl)oxirane with the formula (XIII) indicated below where R<9> = CH3] and (S)-2-bromo-1,4-di-(methanesulfonyloxy)butane [ with the formula Xa given below, where R<8> = CH3] are known compounds which can both be prepared according to Shibata et al., Heterocycles, vol. 24, pp. 1331-1346 (1986); the former also according to Boger et al., J. Org. Chem., vol. 46, pp. 1208-1210 (1981).

De forbindelser som kan fremstilles ved hjelp av mellomproduktene ifølge oppfinnelsen, er 5R,6S-6-(lR-hydroksyetyl)-2-(lR-l-okso-3S-tiolanyltio)-3-karboksylater med den absolutte stereokjemiske formel The compounds that can be prepared using the intermediates according to the invention are 5R,6S-6-(1R-hydroxyethyl)-2-(1R-1-oxo-3S-thiolanylthio)-3-carboxylates with the absolute stereochemical formula

hvor R er hydrogen eller pivaloyloksymetyl; og de farmasøytisk akseptable kationiske salter derav når R er hdyrogen. Mellomproduktene ifølge oppfinnelsen har den absolutte stereokjemiske formel where R is hydrogen or pivaloyloxymethyl; and the pharmaceutically acceptable cationic salts thereof when R is hydrogen. The intermediates according to the invention have the absolute stereochemical formula

hvor R<4> er hydrogen eller t-butyldimetylsilyl,- R<5> er hydrogen, -CH2-CX=CH2, eller-CH2-0-CO-C(CH3)3 (med det forbehold at R<5 >er -CH2-CX=CH2 når R<4> er hydrogen) ; og X er klor,- eller et salt derav når R<5> er hydrogen. where R<4> is hydrogen or t-butyldimethylsilyl,- R<5> is hydrogen, -CH2-CX=CH2, or-CH2-0-CO-C(CH3)3 (with the proviso that R<5> is -CH2-CX=CH2 when R<4> is hydrogen); and X is chlorine or a salt thereof when R<5> is hydrogen.

De kan fremstilles fra forbindelser med formelen They can be prepared from compounds of the formula

hvor R<6> er t-butyldimetylsilyl-beskyttelsesgruppe; R<7> er hydrogen eller som på sin side kan fremstilles fra forbindelser med formelen hvor R<10> er -CH2-CX=CH2 eller -CH2-0-CO-C (CH3) 3, X er hydrogen eller klor, Y er CH3CO, M®, eller M® <©>S where R<6> is t-butyldimethylsilyl protecting group; R<7> is hydrogen or which in turn can be prepared from compounds with the formula where R<10> is -CH2-CX=CH2 or -CH2-0-CO-C (CH3) 3, X is hydrogen or chlorine, Y is CH3CO, M®, or M® <©>S

og M© er et and M© is a

alkalimetallkation, fortrinnsvis Na®. alkali metal cation, preferably Na®.

Fremstilling av forbindelsene med formel II fra fobindel-sene med formel IV er gjenstand for stamsøknaden, patent 173.654 . Preparation of the compounds of formula II from the fobin parts of formula IV is the subject of the parent application, patent 173,654.

Eksempel 1 Example 1

a) Natrium-3S-(tio(tiokarbonyl)tio)tiolan-lR-oksyd ( VII Ia, M® = Na®) a) Sodium 3S-(thio(thiocarbonyl)thio)thiolane-1R-oxide ( VII Ia, M® = Na®)

I en flammetørket kolbe ble en oppløsning av 1,78 g (10 mmol) 3S-(acetyltio)tiolan-IR-oksyd i 6 ml etanol under nitrogen avkjølt til -5°C. Natriumetoksyd (21 vektprosent i etanol, 3,73 ml, 10 mmol) ble tilsatt og blandingen omrørt ved In a flame-dried flask, a solution of 1.78 g (10 mmol) of 3S-(acetylthio)thiolane IR-oxide in 6 ml of ethanol under nitrogen was cooled to -5°C. Sodium ethoxide (21% by weight in ethanol, 3.73 mL, 10 mmol) was added and the mixture stirred at

-5°C i 30 min., deretter avkjølt til -20°C, hvorpå 3,0 ml (50 mmol) karbondisulfid ble tilsatt og omrøringen fortsatt i 30 minutter. Til dette ble det tilsatt 75 ml vannfri tetrahydrofuran. Den resulterende blanding ble omrørt i noen minutter, podet med krystaller av tittelforbindelsen, avkjølt og holdt ved 15°C og omrørt inntil krystallisasjonen var fullstendig. Blandingen ble filtrert, vasket med kald tetrahydrofuran og deretter med etyleter. De resulterende krystaller ble luft-tørket under nitrogen for å gi 2,10 g tittelprodukt solvati-sert med 0,5 molar ekvivalenter tetrahydrofuran. Ytterligere 592 mg ble gjenvunnet ved opparbeidning av moderluten; smp. 120-121°C (dekomp.), sortner ved 155-156°C; [å]D = -79,52° (c = 0, 05, i H20) . b) 3S,4S-3-[1R-1-(dimetyl-t-butylsilyloksy)etyl]-4-[lR-okso-3S-tiolanyltio(tiokarbonyl)tio]-2-azetidinon (VI, R<7>=H, -5°C for 30 min., then cooled to -20°C, whereupon 3.0 ml (50 mmol) carbon disulfide was added and stirring continued for 30 min. To this was added 75 ml of anhydrous tetrahydrofuran. The resulting mixture was stirred for a few minutes, seeded with crystals of the title compound, cooled and kept at 15°C and stirred until crystallization was complete. The mixture was filtered, washed with cold tetrahydrofuran and then with ethyl ether. The resulting crystals were air-dried under nitrogen to give 2.10 g of the title product solvated with 0.5 molar equivalents of tetrahydrofuran. A further 592 mg was recovered by working up the mother liquor; m.p. 120-121°C (decomp.), blackens at 155-156°C; [å]D = -79.52° (c = 0.05, in H 2 O). b) 3S,4S-3-[1R-1-(dimethyl-t-butylsilyloxy)ethyl]-4-[1R-oxo-3S-thiolanylthio(thiocarbonyl)thio]-2-azetidinone (VI, R<7>= H,

R6=Me. tBuSi) R6=Me. tBuSi)

I en flammetørket kolbe ble en oppløsning av 3R,4R-4-acetoksy-3-[IR-(dimetyl-t-butylsilyloksy)etyl]-2-azetidinon [1,87 g, 6,5 mmol; Leanza et al., Tetrahedron 39, s. 2505-2513 In a flame-dried flask, a solution of 3R,4R-4-acetoxy-3-[IR-(dimethyl-t-butylsilyloxy)ethyl]-2-azetidinone [1.87 g, 6.5 mmol; Leanza et al., Tetrahedron 39, pp. 2505-2513

(1983)] i 20 ml isopropylalkohol og CS2 (0,15 ml, 2,5 mmol) kombinert under nitrogen og akvjølt til 3°C. Produktet fra trinn a) (1,36 g, 5 mmol) ble tilsatt porsjonsvis hvorunder temperaturen ble holdt ved 3°C. Etter 0,5 timer ved 3°C ble reaksjonen avbrutt med 40 ml mettet ammoniumkloridoppløsning og blandingen deretter tilsatt 50 ml etylacetat. Det organiske lag ble fraskilt og det vandige lag ekstrahert med ytterligere 2 x 25 ml etylacetat. De kombinerte etylacetat-lagene ble vasket med 2 x 20 ml H20 og 2 x 20 ml 20% CaCl2, tørket over MgS04, filtrert og konsentrert i vakuum for å gi det rå tittelprodukt, 3,04 g. Sistnevnte ble oppløst i ca. 2 ml aceton og dråpevis tilsatt isopropyleter inntil utfelling av faststoff startet, hvorpå blandingen ble omrørt i l time og deretter under omrøring hurtig tilsatt 120 ml petroleter. Det resulterende faststoff ble frafiltrert, lufttørket, deretter tørket i vakuum og tilslutt kromatografert på silikagel ved bruk av 19:1 etylacetat:metanol som eluent for å gi 1,35 g (61%) renset tittelprodukt. Omkrystallisasjon fra 4 ml aceton etter samme fremgangsmåte ga 1,15 g produkt; [å]D = +109,36° (c = 0,20, GHC13) , pnmr (CDC13) (delta) (ppm) 300 MHz: 0,05 (s, 3H), 0,86 (s, 9H), 1,18 (s, 3H), 1,74 (s, 2H), 2,68 (m, 3H), 2,82 (m, 1H), 3,17 (m, 2H), 3,74 (q, 1H), 4,25 (t, 1H), 4,52 (t, 1H), 5,61 (S, 1H), 6,52 (S,1H), 7,20 (s, 1H). (1983)] in 20 mL of isopropyl alcohol and CS2 (0.15 mL, 2.5 mmol) combined under nitrogen and cooled to 3°C. The product from step a) (1.36 g, 5 mmol) was added portionwise during which the temperature was kept at 3°C. After 0.5 hours at 3°C, the reaction was stopped with 40 ml of saturated ammonium chloride solution and 50 ml of ethyl acetate was then added to the mixture. The organic layer was separated and the aqueous layer extracted with an additional 2 x 25 mL of ethyl acetate. The combined ethyl acetate layers were washed with 2 x 20 mL H 2 O and 2 x 20 mL 20% CaCl 2 , dried over MgSO 4 , filtered and concentrated in vacuo to give the crude title product, 3.04 g. The latter was dissolved in ca. 2 ml of acetone and isopropyl ether added dropwise until precipitation of solids started, after which the mixture was stirred for 1 hour and then, while stirring, quickly added 120 ml of petroleum ether. The resulting solid was filtered off, air dried, then dried in vacuo and finally chromatographed on silica gel using 19:1 ethyl acetate:methanol as eluent to give 1.35 g (61%) of purified title product. Recrystallization from 4 ml of acetone following the same procedure gave 1.15 g of product; [å]D = +109.36° (c = 0.20, GHCCl 3 ), pnmr (CDCCl 3 ) (delta) (ppm) 300 MHz: 0.05 (s, 3H), 0.86 (s, 9H) , 1.18 (s, 3H), 1.74 (s, 2H), 2.68 (m, 3H), 2.82 (m, 1H), 3.17 (m, 2H), 3.74 ( q, 1H), 4.25 (t, 1H), 4.52 (t, 1H), 5.61 (S, 1H), 6.52 (S, 1H), 7.20 (s, 1H).

c) 3S,4R-N-[(2-klorallyloksy)oksalyl]-3-[IR-(dimetyl-t-butylsilyloksy) etyl] -4-[lR-okso-3S-tiolanyltio(tio-karbonyl) tio]-2-azetidinon c) 3S,4R-N-[(2-chloroallyloxy)oxalyl]-3-[IR-(dimethyl-t-butylsilyloxy)ethyl]-4-[1R-oxo-3S-thiolanylthio(thio-carbonyl)thio]- 2-azetidinone

( VI, R6=Me, tBuSi. R7=C0C00CH, CC1CH. (VI, R6=Me, tBuSi. R7=C0C00CH, CC1CH.

En flammetørket, trehalset kolbe forsynt med en dråpetrakt og et lavtemperatur-termometer ble under N2-atmosfære tilsatt produktet fra trinn b) (878 mg, 2 mmol) og 15 ml tørr metylenklorid (sendt gjennom nøytral aluminiumoksyd) . Reaksjonsblandingen ble avkjølt til -50° til -55°C innvendig temperatur og tilsatt N,N-diisopropyletylamin (0,45 ml, To a flame-dried, three-necked flask fitted with a dropping funnel and a low-temperature thermometer, under a N 2 atmosphere, was added the product from step b) (878 mg, 2 mmol) and 15 mL of dry methylene chloride (passed through neutral alumina). The reaction mixture was cooled to -50° to -55°C internal temperature and added N,N-diisopropylethylamine (0.45 mL,

2,6 mmol), hvorunder temperaturen ble holdt lavere enn 50°C. Deretter ble 2-klorallyl-oksalofluorid (0,34 ml, 2,6 mmol) tilsatt så rakst som mulig, hvorunder temperaturen igjen ble holdt lavere enn 50°C, og reaksjonsblandingen ble omrørt i 50 minutter til ved -50° til -55°C. Reaksjonen ble avbrutt med 15 ml H20, hvorpå blandingen fikk oppvarmes til 0°C og ble fortynnet med 20 ml frisk CH2C12. Det organiske lag ble fraskilt, vasket 1 x 15 ml H20, 1 x 20 ml pH 7 buffer og 1 x 25 ml mettet NaCl, tørket over MgS04, filtrert og konsentrert i 2.6 mmol), during which the temperature was kept lower than 50°C. Then 2-chloroallyl oxalofluoride (0.34 mL, 2.6 mmol) was added as quickly as possible, during which the temperature was again kept below 50°C, and the reaction mixture was stirred for another 50 minutes at -50° to -55 °C. The reaction was quenched with 15 ml of H 2 O, after which the mixture was allowed to warm to 0°C and was diluted with 20 ml of fresh CH 2 Cl 2 . The organic layer was separated, washed 1 x 15 ml H 2 O, 1 x 20 ml pH 7 buffer and 1 x 25 ml saturated NaCl, dried over MgSO 4 , filtered and concentrated in

vakuum for å gi 1,05 g tittelprodukt som et gult skum, som i sin helhet ble benyttet direkte i det neste trinn. vacuum to give 1.05 g of the title product as a yellow foam, which was used in its entirety directly in the next step.

d) 2-kloarallyl-5R,6S-6-[IR-(dimetyl-6-butylsilyloksy)etyl]-2-(lR-okso-3S-tiolanyltio)-2-penem-3-karboksylat d) 2-chloroallyl-5R,6S-6-[1R-(dimethyl-6-butylsilyloxy)ethyl]-2-(1R-oxo-3S-thiolanylthio)-2-penem-3-carboxylate

( IV. R4=Me„ tBuSi. RS=CH, CC1CH; (IV. R4=Me„ tBuSi. RS=CH, CC1CH;

En flammetørket, trehalset kolbe forsynt med en kjøler og en utlignende dråpetrakt ble under N2-atmosfære tilsatt produktet fra trinn c) (1,05 g, 2 mmol) og 80 ml etanol-fri kloroform. Reaksjonsblandingen ble oppvarmet til svakt tilbakeløp og trietylafosfitt (0,74 ml, 48 mmol) i 10 ml etanolfri kloroform dråpevis tilsatt i løpet av timer. Blandingen ble holdt under svakt tilbakeløp i 10 timer til. Reaksjonsblandingen ble avkjølt til romtemperatur og konsentrert i vakuum. Residuet ble oppløst i 5 ml etylacetat. Isopropyleter (40 ml) ble tilsatt dråpevis under omrøring fra krystal-lisasjonsstart. Tilslutt ble 40 ml petroleter tilsatt dråpevis, blandingen filtrert og faststoffet tørket for å gi 0,47 g (44%) produkt; smp. 140-141°C; [å]D = +36,78° (c = 0,5, CHC13) . To a flame-dried, three-necked flask fitted with a condenser and an equalizing dropping funnel, under a N 2 atmosphere, was added the product from step c) (1.05 g, 2 mmol) and 80 mL of ethanol-free chloroform. The reaction mixture was heated to gentle reflux and triethyl phosphite (0.74 mL, 48 mmol) in 10 mL of ethanol-free chloroform was added dropwise over the course of hours. The mixture was kept under gentle reflux for another 10 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was dissolved in 5 ml of ethyl acetate. Isopropyl ether (40 ml) was added dropwise with stirring from the start of crystallization. Finally, 40 ml of petroleum ether was added dropwise, the mixture filtered and the solid dried to give 0.47 g (44%) of product; m.p. 140-141°C; [o]D = +36.78° (c = 0.5, CHCl 3 ).

e) 2-kloarallyl-5R,6S-6-(lR-hydroksyetyl)-2-(lR-okso-3S-tiolanyltio)-2-penem-3-karboksylat e) 2-chloroallyl-5R,6S-6-(1R-hydroxyethyl)-2-(1R-oxo-3S-thiolanylthio)-2-penem-3-carboxylate

( IV. R<4>=H. R5=CH, CC1CH., (IV. R<4>=H. R5=CH, CC1CH.,

En flammetørket, trehalset kolbe forsynt med et termometer og to dråpetrakter ble under N2-atmosfære tilsatt produktet ifølge oppfinnelsen fra trinn d) (0,25 g, 0,46 mmol) og 0,5 ml tørr tetrahydrofuran. Til den omrørte reaksjonsblandingen ble det tilsatt iseddik (0,26 ml, 4,6 mmol), fulgt av tetrabutylammoniumfluorid i tetrahydrofuran (IM, 1,38 ml). Den resulterende oppløsning ble omrørt i 16 timer ved romtemperatur, fortynnet med 15 ml etylacetat og 4 ml vann, pH justert til 6,4 med kaliumacetat, lagene separert og det organiske lag vasket 3 x 3 ml vann. Sistnevnte ble kombinert og ekstrahert 3 x 3 ml CH2C12. De kombinerte organiske lagene To a flame-dried, three-necked flask fitted with a thermometer and two dropping funnels, under a N 2 atmosphere, was added the product according to the invention from step d) (0.25 g, 0.46 mmol) and 0.5 ml of dry tetrahydrofuran. To the stirred reaction mixture was added glacial acetic acid (0.26 mL, 4.6 mmol), followed by tetrabutylammonium fluoride in tetrahydrofuran (1 M, 1.38 mL). The resulting solution was stirred for 16 hours at room temperature, diluted with 15 ml of ethyl acetate and 4 ml of water, pH adjusted to 6.4 with potassium acetate, the layers separated and the organic layer washed 3 x 3 ml of water. The latter were combined and extracted 3 x 3 mL CH 2 Cl 2 . The combined organic layers

(etylacetat og CH2C12) ble tørket over Na2S04, filtrert og konsentrert i vakuum for å gi et råprodukt, 0,46 g. Råproduktet ble tatt opp i 25 ml etylacetat og vasket 3 x 6 ml H20. Det organiske lag ble tørket over Na2S04, filtrert og inndampet for å gi renset tittelprodukt, 88 mg; smp. 177-178°C; [å]D = +45,28° (c = 0,25 i dimetylsulfoksyd). (ethyl acetate and CH 2 Cl 2 ) was dried over Na 2 SO 4 , filtered and concentrated in vacuo to give a crude product, 0.46 g. The crude product was taken up in 25 mL ethyl acetate and washed 3 x 6 mL H 2 O. The organic layer was dried over Na 2 SO 4 , filtered and evaporated to give purified title product, 88 mg; m.p. 177-178°C; [α]D = +45.28° (c = 0.25 in dimethylsulfoxide).

Omdannelse av en forbindelse ifølcre oppfinnelsen Conversion of a compound according to the invention

Natrium-5R,6S-6-(lR-hydroksyetyl)-2-(lR-okso-3S-tiolanyltio)-2- penem- 3- karboksylat ( II, R=Na) Sodium 5R,6S-6-(1R-hydroxyethyl)-2-(1R-oxo-3S-thiolanylthio)-2- penem- 3-carboxylate ( II, R=Na)

En flammetørket kolbe svøpt i aluminiumsfolie ble under N2 tilsatt produktet fra eksempel le) (3,60 g, 8,5 mmol) i 115 ml avgasset CH2C12, hvorpå trifenylfosfin (0,72 g, 2,75 mmol), natrium-2-etylheksanoat (6,72 ml av 1,39M i etylacetat, 9,34 mmol) og tetrakis(trifenylfosfin)palladium (0,72 g, 0,62 mmol) ble tilsatt. Reaksjonsblnadingen ble omrørt ved romtemperatur i 50 minutter, hvorpå 72 mg hver av trifenylfosfin og tetra-kis (trif enylf osf in) palladium ble tilsatt og reaksjonsblandingen omrørt ved romtemperatur i 20 minutter til. Etylacetat av HPLC-kvalitet (150 ml) ble tilsatt til reaksjonsblandingen i løpet av 15 minutter. Reaksjonsblandingen ble filtrert og faststoffet lufftørket for å gi råproduktet, 4,97 g. Sistnevnte ble oppslemmet med 45 ml etylacetat i 45 minutter, filtrert og tørket for å gi 3,96 g av det fremdeles rå produkt. Sistnevnte ble tatt opp i 70 ml vann, behandlet med aktivkull, filtrert og filtratet frysetørket for å gi tittel-produktet, 2,63 g. To a flame-dried flask wrapped in aluminum foil, under N2 was added the product from example le) (3.60 g, 8.5 mmol) in 115 ml of degassed CH2Cl2, after which triphenylphosphine (0.72 g, 2.75 mmol), sodium-2- ethyl hexanoate (6.72 mL of 1.39M in ethyl acetate, 9.34 mmol) and tetrakis(triphenylphosphine)palladium (0.72 g, 0.62 mmol) were added. The reaction mixture was stirred at room temperature for 50 minutes, after which 72 mg each of triphenylphosphine and tetrakis(triphenylphosphine)palladium were added and the reaction mixture stirred at room temperature for another 20 minutes. HPLC grade ethyl acetate (150 mL) was added to the reaction mixture over 15 minutes. The reaction mixture was filtered and the solid air dried to give the crude product, 4.97 g. The latter was slurried with 45 ml of ethyl acetate for 45 minutes, filtered and dried to give 3.96 g of the still crude product. The latter was taken up in 70 ml of water, treated with activated charcoal, filtered and the filtrate freeze-dried to give the title product, 2.63 g.

Claims (1)

Mellomprodukt,intermediate product, karakterisert ved at den absolutte stereokjemiske formelcharacterized in that the absolute stereochemical formula hvor R<4> er hydrogen eller dimetyl-t-butylsilylgruppe; R<5> er hydrogen,where R<4> is hydrogen or dimethyl-t-butylsilyl group; R<5> is hydrogen, og X er klor; med det forbehold at Rs er -CH2-CX=CH2 når R<4> er hydrogen; eller et salt derav når R<5> er hydrogen.and X is chlorine; with the proviso that R s is -CH 2 -CX=CH 2 when R<4> is hydrogen; or a salt thereof when R<5> is hydrogen.
NO923722A 1987-05-11 1992-09-24 Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative NO180489C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO890078A NO173654C (en) 1987-05-11 1989-01-09 Analogous Procedures for Preparation of Therapeutically Active Diastereomers 5R, 6S-6- (1R-Hydroxyethyl-2- (cis-1-oxo-3-thiolanylthio) -2-penem-3-carboxylic acids
NO923722A NO180489C (en) 1987-05-11 1992-09-24 Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1987/001114 WO1988008845A1 (en) 1987-05-11 1987-05-11 Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
NO890078A NO173654C (en) 1987-05-11 1989-01-09 Analogous Procedures for Preparation of Therapeutically Active Diastereomers 5R, 6S-6- (1R-Hydroxyethyl-2- (cis-1-oxo-3-thiolanylthio) -2-penem-3-carboxylic acids
NO923722A NO180489C (en) 1987-05-11 1992-09-24 Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative

Publications (4)

Publication Number Publication Date
NO923722L NO923722L (en) 1989-01-09
NO923722D0 NO923722D0 (en) 1992-09-24
NO180489B true NO180489B (en) 1997-01-20
NO180489C NO180489C (en) 1997-04-30

Family

ID=27353082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923722A NO180489C (en) 1987-05-11 1992-09-24 Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative

Country Status (1)

Country Link
NO (1) NO180489C (en)

Also Published As

Publication number Publication date
NO923722D0 (en) 1992-09-24
NO180489C (en) 1997-04-30
NO923722L (en) 1989-01-09

Similar Documents

Publication Publication Date Title
US4174316A (en) 4-Iodomethylazetidin-2-one
DE60221130T2 (en) 2 PYRROLIDONE DERIVATIVES AS PROSTANOID AGONISTS
US5281612A (en) Naphthyridine antibacterial agents
FI96423B (en) Process for the preparation of therapeutically useful diastereomeric 5R, 6S-6- (1R-hydroxyethyl) -2- (cis-1-oxo-3-thiolanylthio) -2-penem-3-carboxylic acid derivatives
WO2008035153A2 (en) Process for the preparation of beta-lactam antibiotic
IE842848L (en) Producing penems
DE3817808A1 (en) METHOD FOR PRODUCING 2-SUBSTITUTED PYRROL
NO890521L (en) SUBSTITUTED PYRIMIDINES.
NO180489B (en) Intermediate which is an optionally protected 5R, 6S-6- (1R-hydroxyethyl) -2- (1S-oxo-3R thiolanylthio) -2-penem-3-carboxylic acid derivative
NZ199487A (en) Azabicycloheptene derivatives,intermediates and pharmaceutical compositions
DK170667B1 (en) Process for the preparation of the diastereomeric 4-acetoxy-3-hydroxyethyl-azetidinones
NO171501B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-METHOXYMETHYLPENEM DERIVATIVES
JP2004505968A (en) Intermediates of carbapenem antibiotics and their preparation
JPS62294685A (en) Manufacture of penem derivative
NO309475B1 (en) Thiazolidinone compounds and therapeutic or prophylactic agent against angina pectoris comprising the compounds as active ingredient
NO167573B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE (5R, 6S,) - 6 - ((R) -1-HYDROXYTHYL) -2-AZACYCLOALKYLTIO-2-PENEM-3-CARBOXYL ACID DERIVATIVES.
EP0468258A1 (en) Substituted pyrido-oxazines
US4751297A (en) Method for preparation of azetidinone-1-oxoacetate by oxidation of the corresponding 2-hydroxyacetate
NO174054B (en) PROCEDURE FOR MANUFACTURING INTERMEDIATES FOR PENEMS
US5191077A (en) Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
NO860104L (en) INTERMEDIATE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 7-OXO-4-TIA-1-AZABICYCLO (3,2,0) HEPT-2-EN-DERIVATES.
KR0180583B1 (en) Phenem derivative
JP3684339B2 (en) Method for producing carbapenem compounds
HU194568B (en) Process for producing 2-/alkyl-thio/peneme derivatives
PL144040B1 (en) Method of obtaining derivatives of 1,1-dioxide of 6-/aminomethylo/penicillanic acid